N-(3-(4-hydroxybenzylidene)-2-oxoindolin-5-yl)-3-(piperidin-1-yl)propanamide

ID: ALA4741285

PubChem CID: 162647003

Max Phase: Preclinical

Molecular Formula: C23H25N3O3

Molecular Weight: 391.47

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(CCN1CCCCC1)Nc1ccc2c(c1)/C(=C\c1ccc(O)cc1)C(=O)N2

Standard InChI:  InChI=1S/C23H25N3O3/c27-18-7-4-16(5-8-18)14-20-19-15-17(6-9-21(19)25-23(20)29)24-22(28)10-13-26-11-2-1-3-12-26/h4-9,14-15,27H,1-3,10-13H2,(H,24,28)(H,25,29)/b20-14+

Standard InChI Key:  GRZZLQABVTZLJZ-XSFVSMFZSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   30.8826  -12.4683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8815  -13.2879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5895  -13.6968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5877  -12.0595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2964  -12.4647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2966  -13.2833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0753  -13.5361    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.5563  -12.8736    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0749  -12.2116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1748  -12.0599    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.4672  -12.4687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4674  -13.2858    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.3735  -12.8733    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.3271  -11.4343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7801  -10.8272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0364  -10.0516    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4902   -9.4449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6900   -9.6148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4389  -10.3969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9868  -11.0003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1421   -9.0084    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.7594  -12.0602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0518  -12.4690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3440  -12.0606    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.3438  -11.2434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6364  -12.4693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9286  -12.0609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6360  -10.8350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9284  -11.2437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  5  1  0
  1 10  1  0
 10 11  1  0
 11 12  2  0
  8 13  2  0
  9 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 18 21  1  0
 11 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  1  0
 26 27  1  0
 25 28  1  0
 27 29  1  0
 29 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4741285

    ---

Associated Targets(Human)

PAK1 Tchem Serine/threonine-protein kinase PAK 1 (2601 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 391.47Molecular Weight (Monoisotopic): 391.1896AlogP: 3.70#Rotatable Bonds: 5
Polar Surface Area: 81.67Molecular Species: BASEHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 9.61CX Basic pKa: 9.01CX LogP: 2.58CX LogD: 1.33
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.68Np Likeness Score: -1.04

References

1. Yao D,Ruhan A,Jiang J,Huang J,Wang J,Han W.  (2020)  Design, synthesis and biological evaluation of 2-indolinone derivatives as PAK1 inhibitors in MDA-MB-231 cells.,  30  (17): [PMID:32738980] [10.1016/j.bmcl.2020.127355]

Source